Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.

Objective: To determine the long-term hearing outcome in patients with intractable vertigo caused by unilateral Ménière's disease who were treated with intratympanic injection of gentamicin.

Study Design: The study was a longitudinal analysis of hearing and control of vertigo in patients with unilateral Ménière's disease who received intratympanic gentamicin.

Methods: Pure-tone thresholds and speech discrimination scores on audiometry were analyzed, along with the control of vertigo.